PDCD1 and hemophilia A: Likewise, patients that previously had developed inhibitors and underwent successful ITI also showed an elevated exhaustion ratio, both during therapy and after its completion (Figure 7G), suggesting that successful ITI establishes PD-1–mediated immune tolerance in hemophilia A patients.